Data as of Oct 28, 2026.

vsCompare their flowsaskIQ about these two fundsAsk the committee about these two funds
Across categories

FXI vs IBB: Differences, Returns & Fees

Share
Share on XDownload as PDF

Over the year to Oct 28, 2026, FXI returned −19.1% to IBB's +37.5%, and IBB charges 0.44% to FXI's 0.73%.

askIQ about this page

askIQ about FXI and IBB

Net assets: $3.7bn on Oct 28, 2026 for iShares China Large-Cap ETF, and $11.0bn on Oct 27, 2026 for iShares Biotechnology ETF.

At a glance
−19.1%
FXI total return, 1 year
+37.5%
IBB total return, 1 year
0.73%
FXI expense ratio
0.44%
IBB expense ratio

Pair scorecard

IBB costs 0.29 points a year less; their one-year returns differ by 56.6 points; IBB is 2.9 times larger.

FXI vs IBB: Differences, Returns & Fees
MeasureFXIIBB
Return
Total return, 1 year−19.1%+37.5%
Drawdown
Below its high32.7%, high on Feb 17, 2021
Benchmark
What it tracksFTSE China 50 IndexBiotech
Cost and size
Expense ratio0.73%0.44%
Net assets, as of Oct 26, 2026$3.7bn$10.7bn
Active share vs the S&P 50099%
Holdings
Holdings in common2%
Top ten holdings, share of the fund58.4%50%

Holdings in common uses holdings dated Oct 27, 2026. Method

What they share

2%

By the books each fund has filed, FXI and IBB hold 2% of their money in the same securities at the same weight. Holdings dated Oct 27, 2026.

0 half 100%

half

2% in common

Positions both hold · largest shared weight first FXI IBB
BEONE MEDICINES AG 2.11% 2.15%
Only in one fund ↓
Only in FXI
CHINA CONSTRUCTION BANK CORP H 9.81%
ALIBABA GROUP HOLDING 8.63%
TENCENT HOLDINGS 8.60%
INDUSTRIAL AND COMMERCIAL BANK OF 6.69%
XIAOMI 4.86%
BANK OF CHINA LTD H 4.76%
MEITUAN 4.58%
NETEASE 3.85%
Only in IBB
GILEAD SCIENCES 8.56%
AMGEN INC 8.20%
VERTEX PHARMACEUTICALS 7.53%
REGENERON PHARMACEUTICALS 5.64%
MODERNA 5.29%
NATERA 3.85%
ARGENX SE ADR 3.42%
ILLUMINA INC 2.93%
Check overlap with more funds →

Side by side

FXI iShares China Large-Cap ETF IBB iShares Biotechnology ETF
Where it sits Stock ETF Thematic ETF
What it is Tracks an index of China Large-Cap Biotech
Total return, 1 year −19.1% +37.5%
Expense ratio 0.73% 0.44%
Already in the S&P 500 0.0% 40.2%
Holdings 51 245
Net assets, FXI as of Oct 28, 2026 and IBB as of Oct 27, 2026 $3.7bn $11.0bn

FXI and IBB on the fields both publish, as of Oct 28, 2026. Source: ETFIQ.

Alert

FXI and IBB flows, by email on Sundays.

One-click unsubscribe. See Privacy.

About each fund
FXI

FXI tracks an index of China Large-Cap. Over the year to Oct 28, 2026 it returned −19.1% with distributions reinvested. The prospectus expense ratio is 0.73% a year. By its holdings published by its issuer for Oct 27, 2026, 0% of the fund by weight is stocks the S&P 500 also holds, across 51 positions, with the top ten at 58.4%. It sat 32.7% below its high of Feb 17, 2021 on Oct 28, 2026.

IBB

By weight, 40% of IBB's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 99%. The top ten holdings are 50% of the fund across 245 positions, as published by its issuer for Oct 27, 2026. Over the year to Oct 28, 2026 the fund returned +37.5% with distributions reinvested.

Questions people ask

Are FXI and IBB in the same category?
FXI is a stock ETF and IBB is a thematic ETF, so they do different jobs. The table compares what both publish: return, cost and holdings.
Which returned more over the last year, FXI or IBB?
In the year to Oct 28, 2026, with distributions reinvested, FXI returned −19.1% and IBB +37.5%.
Which is cheaper, FXI or IBB?
IBB is cheaper, by 0.29 percentage points a year. That is about $29 on $10,000 held for a year. Fees come from each fund's prospectus.
How much do FXI and IBB overlap with the S&P 500?
By their latest filed holdings, 0% of FXI and 40% of IBB by weight is stocks the S&P 500 already holds.
Other comparisons
Cite this pageCitation, APA and Markdown

ETFIQ, FXI against IBB, data as of Oct 28, 2026. https://etfiq.com/compare/any/fxi-vs-ibb

Open data →

Free to use with attribution for data ETFIQ computes; issuer data stays under its owner's terms.